Ionis Pharmaceuticals | IONS - Operating Expenses


Ionis Pharmaceuticals reported $418M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Agios Pharmaceuticals USD 141.54M 11.8M Dec/2025
Alnylam Pharmaceuticals USD 965.32M 84.27M Dec/2025
Arrowhead Research USD 223.22M 10.86M Dec/2025
Astellas Pharma JPY 436.66B 16.75B Dec/2025
BioCryst Pharmaceuticals USD -387.89M 33.7M Sep/2025
BioMarin Pharmaceutical USD 676.18M 131.65M Dec/2025
Celltrion KRW 724.99B 6B Sep/2025
Cspc Pharmaceutical CNY 5.4B 298.41M Sep/2025
Deva Holding AS TRY 1.35B 178.26M Sep/2023
Divis Laboratories Ltd INR 18.32B 1.08B Dec/2025
Esperion Therapeutics USD 67.66M 3.6M Sep/2024
Exelixis USD 362.75M 21.35M Dec/2025
Halozyme Therapeutics USD 211.07M 74.73M Dec/2025
Ionis Pharmaceuticals USD 418M 101.1M Dec/2025
Kangmei Pharma CNY 1.39B 144.29M Sep/2025
Knight Therapeutics CAD 89.06M 2.02M Sep/2024
Laboratorios Farma EUR 313.62M 17.98M Dec/2023
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 21.61M 11.59M Dec/2025
Moderna USD 1.54B 259M Dec/2025
Nektar Therapeutics USD 85.09M 109.3M Sep/2025
Neuren Pharmaceuticals AUD 25.23M 16.54M Dec/2025
Neurocrine Biosciences USD 577.6M 22M Dec/2025
Novartis USD 9.86B 115M Sep/2025
Omeros USD 59.16M 20.13M Jun/2024
OPKO Health USD 205.19M 11.6M Sep/2025
Organigram Holdings CAD 108.11M 17.03M Sep/2025
Ovoca Bio EUR 5.65M 3.45M Jun/2022
Pfizer USD 12.91B 79.89B Dec/2025
Pharma Mar EUR 46.87M 7.24M Dec/2025
PTC Therapeutics USD 246.3M 38.78M Dec/2025
Qiagen NV USD 418.54M 23.25M Dec/2025
Regeneron Pharmaceuticals USD 2.99B 27.97B Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sarepta Therapeutics USD 853.02M 390.78M Dec/2025
Sartorius EUR 693.1M 29.4M Sep/2025
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
Tilray USD 237.52M 17.34M Sep/2025
Ultragenyx Pharmaceutical USD 321M 9.82M Dec/2025
Vertex Pharmaceuticals USD 1.93B 89.1M Dec/2025
Zz Pientze Pharmaceu CNY 1.55B 129.66M Sep/2025